IRIS UniCatt

Bartoccioni, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.643
EU - Europa 1.884
AS - Asia 1.374
SA - Sud America 326
AF - Africa 42
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.278
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.571
SG - Singapore 642
CN - Cina 393
DE - Germania 363
PL - Polonia 334
SE - Svezia 323
BR - Brasile 267
IT - Italia 249
UA - Ucraina 147
FR - Francia 111
GB - Regno Unito 89
IE - Irlanda 85
VN - Vietnam 64
IN - India 63
ID - Indonesia 50
FI - Finlandia 48
CA - Canada 45
RU - Federazione Russa 41
TR - Turchia 23
BD - Bangladesh 22
BE - Belgio 20
AR - Argentina 19
HK - Hong Kong 19
JP - Giappone 18
MX - Messico 18
NL - Olanda 18
IQ - Iraq 15
ZA - Sudafrica 13
AT - Austria 11
CH - Svizzera 11
EC - Ecuador 11
CI - Costa d'Avorio 10
CO - Colombia 9
ES - Italia 9
SA - Arabia Saudita 9
PK - Pakistan 8
UZ - Uzbekistan 7
VE - Venezuela 7
MA - Marocco 6
AU - Australia 5
IL - Israele 5
IR - Iran 5
NO - Norvegia 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LT - Lituania 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CZ - Repubblica Ceca 3
HN - Honduras 3
JO - Giordania 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
GA - Gabon 2
KG - Kirghizistan 2
KR - Corea 2
LB - Libano 2
LV - Lettonia 2
PE - Perù 2
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
HU - Ungheria 1
KE - Kenya 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TO - Tonga 1
TW - Taiwan 1
Totale 6.278
Salva come PNG Salva come JPEG
Città #
Chandler 394
Ashburn 370
Singapore 308
Warsaw 303
Jacksonville 97
Beijing 89
San Mateo 88
Dublin 83
New York 83
Los Angeles 72
Ann Arbor 64
Wilmington 61
Woodbridge 60
Cattolica 58
Chicago 52
Houston 52
Jakarta 48
Nanjing 48
Bremen 47
Dearborn 44
Milan 38
Rome 38
North Bergen 36
Boston 35
Fairfield 32
Redwood City 28
Seattle 27
Moscow 26
Frankfurt am Main 25
Kraków 23
Lawrence 23
Princeton 23
Marseille 22
São Paulo 22
Des Moines 20
Hefei 19
Ho Chi Minh City 19
Dallas 18
Santa Clara 18
Buffalo 17
Denver 17
Nanchang 17
Tokyo 17
Brussels 16
Hanoi 16
Munich 16
Montreal 15
Orem 15
Düsseldorf 14
Hong Kong 14
Atlanta 13
Izmir 13
Cambridge 12
Brooklyn 11
Chennai 11
Washington 11
Abidjan 10
Boardman 10
Lancaster 10
London 10
Columbus 9
Helsinki 9
Mountain View 9
Norwalk 9
Nürnberg 9
Shenyang 9
Stockholm 9
Charlotte 8
Hebei 8
San Francisco 8
Tianjin 8
Turku 8
Zurich 8
Amsterdam 7
Baghdad 7
Brasília 7
Changsha 7
Chengdu 7
Hangzhou 7
Johannesburg 7
Rio de Janeiro 7
University Park 7
Zhengzhou 7
Baltimore 6
Bexley 6
Genoa 6
Jiaxing 6
Manchester 6
Nuremberg 6
Phoenix 6
Poplar 6
Roubaix 6
Shanghai 6
Tashkent 6
Toronto 6
Vienna 6
Curitiba 5
Dhaka 5
Kent 5
Philadelphia 5
Totale 3.477
Salva come PNG Salva come JPEG
Nome #
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis 327
Age-Related Sarcopenia: Diabetes of the Muscle? 300
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 238
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 201
Test domiciliare per la diagnosi integrata di infezione da SARS-CoV-2 199
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 185
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 181
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 173
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 171
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 168
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 166
A Genome-wide Association Study of Myasthenia Gravis 165
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 164
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 162
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 159
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 151
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 146
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 142
Myasthenia gravis with antibodies to MuSK: an update 137
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis 136
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 135
Anti-AChR-negative myasthenia gravis: clinical and immunological features 133
Response to therapy in myasthenia gravis with anti-MuSK antibody 131
Skeletal muscle cells: from local inflammatory response to active immunity 130
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 130
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 126
BAFF serum levels in myasthenia gravis: effects of therapy 125
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 124
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 124
Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis 120
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 116
Management challenges in muscle-specific tyrosine kinase myasthenia gravis. 113
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 112
Early-onset myasthenia gravis: clinical characteristics and response to therapy 88
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 88
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 87
IL-6, monocyte infiltration and parenchymal cells 85
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 83
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 83
Myasthenia gravis and associated autoimmune diseases 81
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 81
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 80
Why Does an I.M. Immunization Work? 66
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 66
Immune-inflammatory response changes in patients with major depressive disorder 58
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 52
MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies 40
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 38
Totale 6.366
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021177 0 0 0 0 0 22 34 9 45 10 47 10
2021/2022461 34 35 11 20 46 11 12 78 21 26 76 91
2022/20231.083 148 140 66 201 64 121 41 104 124 31 30 13
2023/2024599 16 134 24 43 32 78 37 50 10 20 68 87
2024/2025990 26 54 80 19 77 19 28 68 205 76 180 158
2025/20261.494 338 50 117 367 580 42 0 0 0 0 0 0
Totale 6.366